MCB 461 Final Exam 2025
How to distinguish between NK and T cells? - -NK cells rely on diverse repertoire of
surface receptors to decide fate of target, whereas T cells rely on one unique TCR
- CD56 is also found on NK and T cells
-- presence of CD56 without TCR indicates NK cell
How are NK cells activated? - -needs 2 different activating receptors to be triggered
- binding IgG through CD16 is a high confidence message
Killer-cell Immunoglobulin-like Receptors (KIR) - -NK cell receptors that detect HLA-
A/B/C allotypes
- activates or inhibits NK cell response
KIR detects one of 4 shapes of HLA
γ:δ T cells - -goal is to be flexible and bind to variations of certain "themes" -- tissue
maintenance
- themes: certain types of molecules acting as signals
γ:δ T cells have fewer V(D)J blocks therefore less binding variability
γ:δ T cells % of blood lymphocytes - -humans: 5%
What are superantigens and how do they disable to immune system? - -highly toxic
proteins secreted by bacteria to intentionally stimulate T cell activation
- causes non-specific TCR-to-MHC binding of CD4 T cells --> overloads system
How do bacterial proteins such as SSLP7 interfere with IgA function? - -staphylococcal
superantigen-like protein 7 binds IgA and C5
- prevents phagocytosis and blocks C5-mediated MAC formation
Epstein Barr Virus (EBV) - -herpes virus that causes mononucleiosis
- after primary infection is beaten, EBV enters latency and is present for life
Severe Combined Immunodeficiency (SCID) - -lack T cell-dependent antibody
responses and T cell effector responses
Understand importance of CD4 and CCR5 as receptors that bind HIV. - -HIV bind to
CD4 receptors and CCR5 co-receptors on host cells
Highly Active Anti-retroviral Therapy (HAART) - -combination therapy for HIV infection,
in which several antiviral drugs are used together to try and avoid the rapid generation
of drug-resistant mutant viruses that occurs when one of the drugs is used alone.
MCB 461
, MCB 461
CCR5-Δ32 - -CCR5-Δ32 individuals are immune to HIV
- thought to give protection against bubonic plague and small pox
Type I Allergies: IgE and Mast cells - -- antigens bind to IgE on mast cells
- receptors MUST cross-link to send signal into cytoplasm
- cell degranulates and releases mix of inflammatory molecules
considered immediate hypersensitivity because reaction is very fast and can be life-
threatening
Type II Allergies: B cells and Macrophages - -- chemicals introduced to the body result
in altered presentation of cell antigens
- naive B cells recognize antigen as "non-self" and initiate IgG production
- macrophages attack self cells, resulting in tissue damage
Type III Allergies: B cells and Neutrophils - -- antibodies cross-react and form
complexes in blood
- may attach to tissues and result in improper fixation of complement and targeting by
effector cells
*usually occurs with immunotherapy when large amounts of Ig are introduced
Type IV Allergies: Dendritic cells and T cells - -- external molecules form adducts with
normal proteins, altering their form
- altered proteins are presented to CD4 T cells and activate phagocytosis and CD8 T
cell attack
Mast cells - -detect infection, stimulate inflammation, repair damage
- located in tissue, not blodd
- contains granules with proteases and cytokines
mucosal mast cell: releases tryptase against microbes
connective tissue mast cells: releases chymotryptase to remodel tissue
Eosinophils - -has highly toxic pre-formed compounds to attack microbes
- highly damaging to surrounding tissues
Basophils - -similar function to eosinophils
- moves between blood and tissue
IgG4 - -can switch arms with other IgG4 to create 2 different antigen binding specificities
- more likely to bind to pathogens, but can no longer help to fix complement to targets
FcεRI - -receptor that holds IgE tightly onto mast cells
MCB 461